Wedbush Upgrades Pulte to ‘Outperform’ as Inventory Is Undervalued By Investing.com
Investing.com -- Wedbush upgraded PulteGroup Inc (NYSE:) from "outperform" to "impartial" given…
Different title developer EpiPen is undervalued regardless of robust medical information, analyst sees enormous upside potential
Different title developer EpiPen is undervalued regardless of robust medical information, analyst…
